Поисковый запрос: (<.>A=Yukawa, Eiji$<.>) |
Общее количество найденных документов : 21
Показаны документы с 1 по 20
|
|
1.
| Yukawa Влияние возраста и одновременно вводимых противоэпилептических средств на кажущийся клиренс фенобарбитала у больных эпилепсией детей // Якугаку дзасси, 1988. Vol. 108, N 11.-С.1081-1086
|
2.
| Therapeutic drug monitoring services at Kyuchu University Hospital in Japan // DICP, 1990. Vol. 24, N 5.-С.629-632
|
3.
| Yukawa Population pharmacokinetics of phenytoin from routine clinical data in Japan: an update // Chem. and Pharm. Bull., 1990. Vol. 38, N 7.-С.1973-1976
|
4.
| Yukawa Phenobarbitone population pharmacokinetics from routine clinical data: Role of patient characteristics for estimating dosing regimens // J. Pharm. and Pharmacol., 1992. Vol. 44, N 9.-С.755-760
|
5.
| Pharmacokinetic analysis of subcutaneous erythropoietin administration with nonlinear mixed effect model including endogenous production // Brit. J. Clin. Pharmacol., 1998. Vol. 46, N 1.-С.11-19
|
6.
| Pharmacoepidemiologic detection of calcium channel blocker-induced change on digoxin clearance using multiple trough screen analysis // Biopharm. and Drug Dispos., 2002. Vol. 23, N 5.-С.173-181
|
7.
| Yukawa One-point feedback control method for phenytoin dosage adjustment // J. Pharm. and Pharmacol., 1991. Vol. 43, N 7.-С.499-503
|
8.
| Dosing time-dependent tolerance of catalepsy by repetitive administration of haloperidol in mice // J. Pharmacol. and Exp. Ther., 2001. Vol. 298, N 3.-С.964-969
|
9.
| Digoxin population pharmacokinetics from routine clinical data: Role of patient characteristics for estimating dosing regimens // J. Pharm. and Pharmacol., 1992. Vol. 44, N 9.-С.761-765
|
10.
| Yukawa Clinical utility of a new and simple technique for individualizing phenytoin dosage // J. Pharmacobio-Dyn., 1989. Vol. 12, N 4.-С.187-192
|
11.
| Yukawa Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment // Chem. and Pharm. Bull., 1989. Vol. 37, N 12.-С.3363-3366
|
12.
| Chronopharmacology of melatonin in mice to maximize the antitumor effect and minimize the rhythm disturbance effect // J. Pharmacol. and Exp. Ther., 2004. Vol. 308, N 1.-С.378-384
|
13.
| Chronopharmacology of melatonin in mice to maximize the antitumor effect and minimize the rhythm disturbance effect // J. Pharmacol. and Exp. Ther., 2004. Vol. 308, N 1.-С.378-384
|
14.
| Chronopharmacology of melatonin in mice to maximize the antitumor effect and minimize the rhythm disturbance effect // J. Pharmacol. and Exp. Ther., 2004. Vol. 308, N 1.-С.378-384
|
15.
| Chronopharmacology of antitumor effect induced by interferon-'бета' in tumor-bearing mice // J. Pharmacol. and Exp. Ther., 2000. Vol. 294, N 2.-С.746-752
|
16.
| Chronopharmacology of antitumor effect induced by interferon-'бета' in tumor-bearing mice // J. Pharmacol. and Exp. Ther., 2000. Vol. 294, N 2.-С.746-752
|
17.
| Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice // J. Pharmacol. and Exp. Ther., 2003. Vol. 305, N 3.-С.1200-1205
|
18.
| Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice // J. Pharmacol. and Exp. Ther., 2003. Vol. 305, N 3.-С.1200-1205
|
19.
| Higuchi Bayesian prediction of serum phenytoin concentration in a simulation study // Chem. and Pharm. Bull., 1988. Vol. 36, N 5.-С.1914-1918
|
20.
| Yukawa A feasibility study of the multiple-peak approach for pharmacokinetic screening: Population-based investigation of valproic acid relative clearance using routine clinical pharmacokinetic data // J. Pharm. and Pharmacol., 1995. Vol. 47, N 12A.-С.1048-1052
|
&uf('+1W2226#',v2226), ?>
|
|